EU panel backs AstraZeneca hypertension drug baxdrostat
BRUSSELS: AstraZeneca said on Friday a European medicines committee had backed its hypertension pill baxdrostat, branded as Baxfendy, for marketing authorization, potentially making it the first drug of its class to reach patients in the European Union. The Committee for Medicinal Products for Human Use, or CHMP, recommended baxdrostat for adults whose hypertension is insufficiently controlled by at least two medicines. If approved, Baxfendy…
- EgyptGTA 6 shatters entertainment industry records: The Washington Post
- Sudan10 killed as drone strafes South Kordofan gold mine
- Saudi ArabiaUS seeks answers on Nvidia’s sale of chips to China, Bessent says
- OmanOman Flour Mills launches its new corporate identity
- UAE'The town is gone': Brazil storm death toll rises to 5
- QatarQatar Charity provides food baskets to thousands of refugees in Djibouti
- Bahrain24 dead in Nigeria boat accident
- IndiaTemperature in Mumbai drops by about 5 degrees in a day


